United States v. Oscar Guardarrama-Suarez

CourtCourt of Appeals for the Eleventh Circuit
DecidedDecember 19, 2019
Docket18-14378
StatusUnpublished

This text of United States v. Oscar Guardarrama-Suarez (United States v. Oscar Guardarrama-Suarez) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Oscar Guardarrama-Suarez, (11th Cir. 2019).

Opinion

Case: 18-14378 Date Filed: 12/19/2019 Page: 1 of 14

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 18-14378 Non-Argument Calendar ________________________

D.C. Docket No. 1:18-cr-20508-CMA-1

UNITED STATES OF AMERICA,

Plaintiff - Appellee, versus

OSCAR GUARDARRAMA-SUAREZ,

Defendant - Appellant.

________________________

Appeal from the United States District Court for the Southern District of Florida ________________________

(December 19, 2019)

Before JORDAN, JILL PRYOR and TJOFLAT, Circuit Judges.

PER CURIAM: Case: 18-14378 Date Filed: 12/19/2019 Page: 2 of 14

Oscar Guardarrama-Suarez appeals his sentence of 92 months’

imprisonment, which was imposed after he pled guilty to one count of conspiracy

to commit health care and wire fraud. Guardarrama-Suarez argues that the district

court erred in calculating his offense level under the Sentencing Guidelines by

applying a two-level enhancement for using sophisticated means and a four-level

enhancement for playing an aggravating role. We conclude that the district court

did not err in applying either enhancement and affirm Guardarrama-Suarez’s

sentence.

I. BACKGROUND

Guardarrama-Suarez pled guilty, pursuant to a written plea agreement, to

one count of conspiracy to commit health care and wire fraud, in violation of 18

U.S.C. § 1349. As the owner and operator of Antares Pharmacy (“Antares”),

Guardarrama-Suarez paid patient recruiters—including Noemi Delgado, Daris

Hernandez, and someone known only as “J.M.”—to refer fraudulent prescriptions

to Antares.1 Guardarrama-Suarez and others then submitted, or caused the

submission of, claims to the Medicare Part D prescription program for drugs that

were never dispensed to the Medicare beneficiaries. In fact, Antares never

purchased many of the drugs to begin with and therefore never had the drugs to

dispense. As a result of the scheme, the Part D program paid Antares $1,722,080

1 These facts are based on the parties’ proffer agreement.

2 Case: 18-14378 Date Filed: 12/19/2019 Page: 3 of 14

for drugs that were never dispensed. From these proceeds, Guardarrama-Suarez

paid himself $315,000, a company his wife owned approximately $200,000, and a

company his brother owned approximately $600,000.

A grand jury indicted Guardarrama-Suarez for several crimes, including one

count of conspiracy to commit health care and wire fraud, in violation of 18 U.S.C.

§ 1349. Guardarrama-Suarez agreed to plead guilty to the conspiracy charge. In

the plea agreement, the parties agreed that for purposes of sentencing,

Guardarrama-Suarez’s base offense level under the Sentencing Guidelines was

seven and that a sixteen-level enhancement applied based on an actual loss to

Medicare exceeding $1,500,000 but not exceeding $3,500,000. The plea

agreement also stated that the parties remained free to argue for or against any

other enhancement or adjustment at sentencing.

Before sentencing, the probation office prepared a pre-sentence investigation

report (“PSI”). Consistent with the plea agreement, the PSI assigned a base

offense level of seven and a sixteen-level enhancement based on the loss amount.

In addition, the PSI applied a two-level enhancement because the offense involved

a government health program and the loss amount was more than $1,000,000 but

not more than $7,000,000, see U.S.S.G. § 2B1.1(b)(7)(A), (B)(i); a two-level

enhancement because the offense involved sophisticated means, see id.

§ 2B1.1(b)(10)(C); and a four-level aggravating role enhancement because

3 Case: 18-14378 Date Filed: 12/19/2019 Page: 4 of 14

Guardarrama-Suarez was an organizer or leader of criminal activity that involved

five or more participants or was otherwise extensive, see id. § 3B1.1(a). After

applying a three-level reduction for acceptance of responsibility, the PSI calculated

the total offense level as 28.

Guardarrama-Suarez objected to the enhancement for sophisticated means,

arguing that his case was a garden-variety fraud cause. He also objected to the

enhancement for being an organizer or leader because he did not manage or

supervise the patient recruiters and the government failed to identify the requisite

number of participants in the scheme.

In response, the government argued that the sophisticated means

enhancement was appropriate because Guardarrama-Suarez used cash kickbacks to

conceal the fraudulent scheme and because his brother’s company was in fact a

shell company through which he laundered illegal proceeds. The government also

argued that the enhancement for organizing or leading the scheme was appropriate

because Guardarrama-Suarez incorporated, owned, and opened Antares; created

and submitted claims for fraudulent prescriptions without even ordering many of

the drugs; was a signatory for and controlled Antares’ bank accounts; paid the

patient recruiters; and received the largest share of the proceeds of the fraud. The

scheme involved five or more participants—Guardarrama-Suarez, Delgado,

Hernandez, and two employees. Even if five participants were not involved, the

4 Case: 18-14378 Date Filed: 12/19/2019 Page: 5 of 14

scheme was “otherwise extensive,” U.S.S.G. § 3B1.1(a), because it lasted for over

four years, involved at least $1.7 million in actual losses, and was concealed

through cash kickbacks and a shell company.

At the sentencing hearing, Guardarrama-Suarez objected to both

enhancements. He objected for the first time to the statement in the PSI that his

brother’s company was a shell company. He argued that he laundered no money

through his brother’s company and that he was repaying his brother for a loan to

buy the pharmacy. The district court overruled Guardarrama-Suarez’s objections

and applied a two-level sophisticated means enhancement and a four-level

aggravating role enhancement based on the PSI, the government’s responses to

Guardarrama-Suarez’s objections to the PSI, and the government’s arguments in

court. Based on a total offense level of 28 and criminal history category of I, the

district court calculated Guardarrama-Suarez’s guidelines range at 78 to 97

months’ imprisonment. The district court imposed a sentence of 92 months’

imprisonment. This appeal followed.

II. STANDARD OF REVIEW

With respect to the Sentencing Guidelines, we review “purely legal

questions de novo, a district court’s factual findings for clear error, and, in most

cases, a district court’s application of the guidelines to the facts with due

deference.” United States v. Rodriguez-Lopez, 363 F.3d 1134, 1136-37 (11th Cir.

5 Case: 18-14378 Date Filed: 12/19/2019 Page: 6 of 14

2004) (internal quotation marks omitted). “Review for clear error is deferential

and we will not disturb a district court’s findings unless we are left with a definite

and firm conviction that a mistake has been committed.” Id. at 1167 (alterations

adopted) (internal quotation marks omitted) (citations omitted). A district court’s

choice between two permissible views of the evidence cannot be clear error.

United States v. Ndiaye,

Related

United States v. Glover
179 F.3d 1300 (Eleventh Circuit, 1999)
United States v. George A. Vallejo
297 F.3d 1154 (Eleventh Circuit, 2002)
United States v. Omar Rodriguez-Lopez
363 F.3d 1134 (Eleventh Circuit, 2004)
United States v. Amadou Fall Ndiaye
434 F.3d 1270 (Eleventh Circuit, 2006)
United States v. Martinez
584 F.3d 1022 (Eleventh Circuit, 2009)
United States v. Ghertler
605 F.3d 1256 (Eleventh Circuit, 2010)
United States v. Zerry Feaster
798 F.3d 1374 (Eleventh Circuit, 2015)
United States v. Qadir Shabazz
887 F.3d 1204 (Eleventh Circuit, 2018)
United States v. Khaled Elbeblawy
899 F.3d 925 (Eleventh Circuit, 2018)
United States v. James Dixon
901 F.3d 1322 (Eleventh Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Oscar Guardarrama-Suarez, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-oscar-guardarrama-suarez-ca11-2019.